Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

Not Applicable

Terminated

• Conditions: Cervical Cancer

• Registration Number: NCT03613493
• Lead Sponsor: University of Miami

Brief Summary

The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-06-17
• Study Start: 2018-07-10
• Study First Submitted QC: 2018-08-01
• Study First Posted: 2018-08-03
• Primary Completion: 2018-10-01
• Study Completion: 2018-10-01
• Status Verified: 2019-07
• Results First Submitted: 2019-07-10
• Results First Submitted QC: 2019-07-31
• Last Update Submitted: 2019-07-31
• Results First Posted: 2019-08-02
• Last Update Posted: 2019-08-02

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 175

Inclusion Criteria

• Jamaican women, aged 30 to 65.

Exclusion Criteria

• Women who report having had a hysterectomy,
• have had a history of cervical cancer,
• Women who are currently up-to-date on cervical cancer screening (have had a Pap in the last 3 years or have had a Pap smear/HPV co-test within the past 5 years),
• Adults unable to consent, children, pregnant women and prisoners.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number of Participants That Used and Returned Their Self-sampler Kit.	2 weeks	Number of participants that used and returned their self-sampler kit was evaluated.

Trial Locations

Locations (1)

University of Miami; 🇺🇸 Miami, Florida, United States